Friday, 16 June 2017 141 co-expression was quantified. CD206 immunofluorescence of skin biopsies was also performed. Macrophages were co-cultured with 8x10 4 and 2x10 4 fibroblasts in a collagen matrix and within a monolayer respectively. Collagen gel contraction was quantified as a measure of fibrotic activity. CTGF and Collagen mRNA expression from gel matrices and cellular monolayers was quantified by qPCR. Results: CD206 and P2X 7 expression is higher on SSc PBMC-derived macrophages (mean fluorescence 776.1 SD=409.1, 724.4 SD=455.3) compared to healthy controls (mean fluorescence 632.2 SD=73.7, 472.9 SD=25.4). There is significant correlation of CD206 expression to P2X 7 expression (p<0.001, r2=0.76) and CD206 expression is significantly correlated to Rodnan skin score (p<0.05, r2=0.26). P2X 7 expression is positively correlated to skin score. Double positive P2X7 and CD206 cells were seen in a subgroup with higher skin scores. Healthy fibroblasts co-cultured with scleroderma macrophages showed increased collagen mRNA by qPCR compared to co-culture with healthy macrophages (p<0.01). CTGF mRNA was positively correlated with macrophage P2X7 (r2=0.23) and CD206 (r2=0.81) expression. Preliminary work suggests contraction of collagen discs in fibroblast and macrophage co-culture is increased with SSc macrophages compared to healthy controls. Conclusions: Data indicates a correlation between disease severity and CD206 expression by macrophages. Upregulation of CTGF and collagen expression in fibroblasts co-cultured with macrophages expressing high CD206 suggests a role for these cells in pathogenic fibrosis. The co-expression of high levels of P2X 7 with CD206 also indicates a possible role for the purinergic pathway in SSc fibrosis. Future work will examine the mechanism of macrophage-fibroblast cross-talk and investigate the effect of inhibitors of CD206. Objectives: We aimed to investigate whether MAIT cells are involved in systemic lupus erythematous (SLE). Methods: Peripheral blood was collected from SLE patients and healthy volunteers. Informed consent was obtained from all individuals according to institutional ethical guidelines. Disease activity was measured based on the SLE disease activity index (SLEDAI) and a SLEDAI score ≥5 was defined as active disease. Peripheral blood mononuclear cells (PBMC) were stained with antihuman monoclonal antibodies against CD3, γδTCR, Vα7.2TCR, CD161, CD95 (Fas) and CD69, and then analyzed by FACS. CD19 + B cells or CD14 + monocytes were isolated from PBMC of healthy controls (HC) or SLE patients by using magnetic cell sorting. MAIT cells from healthy controls were co-cultured with B cells or monocytes in the presence of MR1 ligand (MR1L), and the expression of CD69 on MAIT cells was evaluated by FACS. Cytokine levels in plasma samples and culture supernatants were measured by ELISA and Bioplex assay. PBMC were cultured in the presence of various cytokines, and CD69 expression on MAIT cells was analyzed by FACS. Results: The frequency of MAIT cells was markedly reduced in SLE. Reduced numbers of MAIT cells were not attributable to the downregulation of surface markers, but were partially due to the enhanced cell death of MAIT cells, possibly by activation-induced cell death. The CD69 expression levels on MAIT cells in SLE correlated with disease activity. Monocytes from patients with SLE exhibited increased ability to induce MAIT cell activation, and the profound MAIT cell activating capacity of lupus monocytes was associated with enhanced IL-12 production in the culture supernatants. The plasma concentration of IL-6, IL-18 and IFNα positively correlated with the expression levels of CD69 on MAIT cells in SLE. MAIT cells were activated by cytokines including IFNα, IL-15, and IL-12 plus IL-18 in the absence of exogenous antigens. Conclusions: These results suggest that MAIT cells reflect the pathological condition of SLE and their activated status correlates with disease activity.
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